E1	Condition:T1 Name:T2
E3	Condition:T3 Name:T4
E7	Observation:T7 Name:T8 Eq-Comparison:E24 Severity:T80
E9	Observation:T9 Name:T10 Eq-Comparison:E27
E13	Condition:T13 Name:T14
E15	Condition:T15 Name:T16
E17	Condition:T17 Name:T18 Temporality:E81
E21	Procedure:T21 Name:T22 Temporality:E84
E22	Age:T42 Eq-Comparison:E23
E23	Eq-Comparison:T57 Operator:T23 Temporal-Unit:T34 Value:T43
E24	Eq-Comparison:T58 Operator:T24 Value:T44
E25	Eq-Comparison:T59 Operator:T25 Temporal-Unit:T35 Value:T47
E26	Eq-Comparison:T60 Operator:T26 Unit:T39 Value:T48
E27	Eq-Comparison:T61 Operator:T27 Unit:T40 Value:T49
E28	Eq-Comparison:T62 Operator:T28 Value:T50 Unit:T123
E29	Eq-Comparison:T63 Operator:T29 Temporal-Unit:T36 Value:T51
E30	Eq-Comparison:T64 Operator:T30 Temporal-Unit:T37 Value:T52
E31	Eq-Comparison:T65 Operator:T31 Value:T53 Unit:T141 Per:T142
E32	Eq-Comparison:T66 Operator:T32 Value:T54 Unit:T147 Per:T41
E2	Or:T67 Arg:T6 Arg2:T5
E4	And:T68 Arg:E1 Arg2:E3
E5	Condition:T69 Name:T70 Severity:T73 Temporality:E8
E6	Or:T71 Arg:T72 Arg2:T73
E8	Eq-Comparison:T74 Temporal-Period:T75
E10	Observation:T76 Name:T77
E12	Study:T78
E14	Modifier:T45 Modifies:T8
E16	Temporal-Connection:T79 Arg:E7 Arg2:E12
E18	Study:T81
E20	And:T82 Arg:E12 Arg2:E18
E33	Eq-Comparison:T46 Temporal-Recency:T83
E34	Eq-Comparison:T84 Temporal-Period:T85
E35	Condition:T86 Name:T87 Temporality:E34 Temporality2:E33 Temporality3:E25
E36	Study:T88
E37	Temporal-Connection:T89 Arg:E25 Arg2:E36
E38	Condition:T90 Name:T91 Severity:T94 Temporality:E39
E39	Eq-Comparison:T92 Temporal-Period:T93
E40	Or:T96 Arg:T95 Arg2:T94
E11	Condition:T11 Name:T12
E41	Negation:T97 Negates:E11
E42	Observation:T98 Name:T99 Stability:T100
E43	And:T101 Arg:E41 Arg2:E42
E44	Condition:T102
E45	Observation:T103 Name:T104 Eq-Comparison:E26
E46	Condition:T105 Name:T106 Severity:T107
E47	Or:T109 Arg:T108 Arg2:T107
E48	Condition:T111 Name:T112
E49	Modifier:T113 Modifies:T112
E50	Modifier:T114 Modifies:T112
E51	Or:T115 Arg:E50 Arg2:E49
E52	Or:T116 Arg:E9 Arg2:E48
E53	Drug:T117 Name:T118 Dose:E28 Temporality:E29
E54	Modifier:T119 Modifies:E53
E55	Modifier:T120
E56	Modifier:T121 Modifies:E53
E57	Or:T122 Arg:E55 Arg2:E56
E58	Drug:T124 Name:T125
E59	Condition:T126 Name:T127
E60	Study:T128
E61	Temporal-Connection:T129 Arg:E29 Arg2:E60
E62	Drug:T130 Name:T131
E63	Drug:T132 Name:T133
E64	Drug:T134 Name:T135 Temporality:E30
E65	Or:T136 Arg:E63 Arg2:E64
E66	Study:T137
E67	Temporal-Connection:T138 Arg:E30 Arg2:E66
E68	Observation:T139 Name:T140 Eq-Comparison:E31
E69	Study:T143
E70	Temporal-Connection:T144 Arg:E68 Arg2:E69
E71	Observation:T145 Name:T146 Eq-Comparison:E32
E72	Study:T148
E73	Temporal-Connection:T149 Arg:E71 Arg2:E72
E74	Condition:T150 Name:T151 Polarity:T152
E19	Eq-Comparison:T19 Value:T20 Unit:T55
E75	Observation:T153 Name:T154 Eq-Comparison:E19
E76	Condition:T155 Name:T156 Temporality:E77
E77	Eq-Comparison:T157 Temporal-Recency:T158
E78	Condition:T159 Name:T160
E79	Or:T161 Arg:E76 Arg2:E78
E80	Modifier:T162 Modifies:T18
E81	Eq-Comparison:T163 Operator:T33 Temporal-Period:T164 Value:T56 Temporal-Unit:T38
E82	Study:T165
E83	Temporal-Connection:T166 Arg:E17 Arg2:E82
E84	Eq-Comparison:T167 Temporal-Period:T168
E85	Condition:T169 Name:T170
E86	Procedure:T171 Name:T172
E87	Or:T173 Arg:E21 Arg2:E86
T1	Condition 110 101	Graves' disease
T2	Condition-Name 110 101	Graves' disease
T3	Condition 131 122	hyperthyroidism
T4	Condition-Name 131 122	hyperthyroidism
T5	Life-Stage-And-Gender 43 39	female
T6	Life-Stage-And-Gender 33 29	Male
T7	Observation 215 204	CAS
T8	Observation-Name 215 204	CAS
T9	Observation 651 604	proptosis
T10	Observation-Name 651 604	proptosis
T13	Condition 1109 1037	immunomodulation
T14	Condition-Name 1109 1037	immunomodulation
T15	Condition 1364 1270	optic neuropathy
T16	Condition-Name 1364 1270	optic neuropathy
T17	Condition 1501 1404	optic nerve
T18	Condition-Name 1501 1404	optic nerve
T21	Procedure 1591 1489	orbital irradiation
T22	Procedure-Name 1591 1489	orbital irradiation
T23	Eq-Operator 45 41	≥
T24	Eq-Operator 219 207	≥
T25	Eq-Operator 375 347	within
T26	Eq-Operator 588 544	≥
T27	Eq-Operator 653 606	≥
T28	Eq-Operator 932 868	≥
T29	Eq-Operator 990 925	within
T30	Eq-Operator 1125 1053	within the past
T31	Eq-Operator 1181 1104	<
T32	Eq-Operator 1241 1156	<
T33	Eq-Operator 1520 1423	within
T34	Eq-Temporal-Unit 55 50	years
T35	Eq-Temporal-Unit 385 356	months
T36	Eq-Temporal-Unit 999 933	weeks
T37	Eq-Temporal-Unit 1135 1062	months
T38	Eq-Temporal-Unit 1539 1441	months
T39	Eq-Unit 594 549	mm
T40	Eq-Unit 659 611	mm
T41	Eq-Unit 1260 1170	mm3
T42	Age 62 57	age
T43	Eq-Value 49 44	18
T44	Eq-Value 222 209	4
T47	Eq-Value 378 349	9
T48	Eq-Value 591 546	2
T49	Eq-Value 656 608	3
T50	Eq-Value 935 870	1
T51	Eq-Value 993 927	3
T52	Eq-Value 1128 1055	9
T53	Eq-Value 1184 1106	6
T54	Eq-Value 1247 1160	1500
T56	Eq-Value 1532 1434	6
T57	Eq-Comparison 55 50	≥ 18 years
T58	Eq-Comparison 222 209	≥ 4
T59	Eq-Comparison 385 356	within 9 months
T60	Eq-Comparison 594 549	≥ 2 mm
T61	Eq-Comparison 672 624	≥ 3 mm above normal
T62	Eq-Comparison 937 872	≥ 1 g
T63	Eq-Comparison 999 933	within 3 weeks
T64	Eq-Comparison 1135 1062	within the past 9 months
T65	Eq-Comparison 1190 1109	< 6g/L
T66	Eq-Comparison 1260 1170	<1500 cells/mm3
T67	Or 36 32	or
T68	And 115 106	with
T69	Condition 178 168	GO
T70	Condition-Name 178 168	GO
T72	Severity 165 155	moderate
T73	Severity 175 165	severe
T71	Or 168 158	to
T74	Eq-Comparison 154 145	active
T75	Eq-Temporal-Period 154 145	active
T76	Observation 209 199	Clinical Activity Score
T77	Observation-Name 209 199	Clinical Activity Score
T78	Study 270 257	Screening
T80	Severity 244 231	severely
T45	Modifier 257 244	affected eye
T79	Temporal-Connection 260 247	at
T81	Study 310 292	Baseline
T82	And 301 283	and
T46	Eq-Comparison 355 327	Onset
T83	Eq-Temporal-Recency 355 327	Onset
T84	Eq-Comparison 365 337	active
T85	Eq-Temporal-Period 365 337	active
T86	Condition 368 340	GO
T87	Condition-Name 368 340	GO
T88	Study 398 369	screening
T89	Temporal-Connection 388 359	of
T90	Condition 441 404	GO
T91	Condition-Name 441 404	GO
T92	Eq-Comparison 438 401	active
T93	Eq-Temporal-Period 438 401	active
T94	Severity 431 394	severe
T95	Severity 417 384	Moderate
T96	Or 422 387	to
T11	Condition 467 427	sight-threatening
T12	Condition-Name 467 427	sight-threatening
T97	Negation 447 409	not
T98	Observation 511 471	daily life
T99	Observation-Name 511 471	daily life
T100	Stability 497 457	impact
T101	And 471 431	but
T102	Condition 569 526	following
T103	Observation 586 542	lid retraction
T104	Observation-Name 586 542	lid retraction
T105	Condition 639 593	soft tissue involvement
T106	Condition-Name 639 593	soft tissue involvement
T107	Severity 615 569	severe
T108	Severity 605 559	moderate
T109	Or 608 562	or
T110	Eq-Unit 672 624	above normal
T111	Condition 735 684	diplopia
T112	Condition-Name 735 684	diplopia
T113	Modifier 726 675	constant
T114	Modifier 714 663	inconstant
T115	Or 717 666	or
T116	Or 703 652	and/or
T117	Drug 862 802	steroid
T118	Drug-Name 862 802	steroid
T119	Modifier 876 815	intravenous
T120	Modifier 881 819	IV
T121	Modifier 891 828	oral
T122	Or 886 823	or
T123	Eq-Unit 937 872	g
T124	Drug 959 894	methylprednisolone
T125	Drug-Name 959 894	methylprednisolone
T126	Condition 983 918	GO
T127	Condition-Name 983 918	GO
T128	Study 1018 952	Screening
T129	Temporal-Connection 1005 939	prior
T130	Drug 1045 975	rituximab
T131	Drug-Name 1045 975	rituximab
T132	Drug 1059 988	tocilizumab
T133	Drug-Name 1059 988	tocilizumab
T134	Drug 1088 1016	monoclonal antibody
T135	Drug-Name 1088 1016	monoclonal antibody
T136	Or 1064 992	or
T137	Study 1153 1080	Baseline
T138	Temporal-Connection 1141 1068	prior
T139	Observation 1179 1102	Total IgG level
T140	Observation-Name 1179 1102	Total IgG level
T141	Eq-Unit 1186 1107	g
T142	Eq-Unit 1190 1109	L
T143	Study 1203 1122	Screening
T144	Temporal-Connection 1193 1112	at
T145	Observation 1239 1154	Absolute neutrophil count
T146	Observation-Name 1239 1154	Absolute neutrophil count
T147	Eq-Unit 1253 1166	cells
T148	Study 1273 1183	Screening
T149	Temporal-Connection 1263 1173	at
T150	Condition 1340 1246	best corrected visual acuity
T151	Condition-Name 1340 1246	best corrected visual acuity
T152	Polarity 1311 1217	decreased
T19	Eq-Comparison 1411 1316	2 lines
T20	Eq-Value 1405 1310	2
T55	Eq-Unit 1411 1316	lines
T153	Observation 1399 1305	decrease in vision
T154	Observation-Name 1399 1305	decrease in vision
T155	Condition 1458 1362	visual field defect
T156	Condition-Name 1458 1362	visual field defect
T157	Eq-Comparison 1438 1342	new
T158	Eq-Temporal-Recency 1438 1342	new
T159	Condition 1476 1379	color defect
T160	Condition-Name 1476 1379	color defect
T161	Or 1463 1366	or
T162	Modifier 1513 1416	involvement
T163	Eq-Comparison 1539 1441	within the last 6 months
T164	Eq-Temporal-Period 1529 1432	last
T165	Study 1552 1454	Screening
T166	Temporal-Connection 1542 1444	at
T167	Eq-Comparison 1571 1469	Previous
T168	Eq-Temporal-Period 1571 1469	Previous
T169	Condition 1609 1507	GO
T170	Condition-Name 1609 1507	GO
T171	Procedure 1602 1500	surgery
T172	Procedure-Name 1602 1500	surgery
T173	Or 1594 1492	or
A1	Life-Stage-And-Gender-Type T5 female
A2	Life-Stage-And-Gender-Type T6 male
A3	Eq-Operator-Value T23 GTEQ
A4	Eq-Operator-Value T24 GTEQ
A5	Eq-Operator-Value T25 LTEQ
A6	Eq-Operator-Value T26 GTEQ
A7	Eq-Operator-Value T27 GTEQ
A8	Eq-Operator-Value T28 GTEQ
A9	Eq-Operator-Value T29 LTEQ
A10	Eq-Operator-Value T30 LTEQ
A11	Eq-Operator-Value T31 LT
A12	Eq-Operator-Value T32 LT
A13	Eq-Operator-Value T33 LTEQ
A14	Eq-Temporal-Unit-Value T34 year
A15	Eq-Temporal-Unit-Value T35 month
A16	Eq-Temporal-Unit-Value T36 week
A17	Eq-Temporal-Unit-Value T37 month
A18	Eq-Temporal-Unit-Value T38 month
A19	Severity-Value T72 moderate
A20	Severity-Value T73 severe
A21	Eq-Temporal-Period-Value T75 present
A22	Observation-Type-Value T77 clinical-score
A23	Severity-Value T80 severe
A24	Temporal-Connection-Type-Value E16 during
A25	Eq-Temporal-Recency-Value T83 first-time
A26	Eq-Temporal-Period-Value T85 present
A27	Temporal-Connection-Type-Value E37 before
A28	Eq-Temporal-Period-Value T93 present
A29	Severity-Value T94 severe
A30	Severity-Value T95 severe
A31	Stability-Value T100 change
A32	Observation-Type-Value T104 measurement
A33	Severity-Value T107 severe
A34	Severity-Value T108 moderate
A35	Eq-Unit-Value T110 ref-range-high
A36	Temporal-Connection-Type-Value E61 before
A37	Temporal-Connection-Type-Value E67 before
A38	Observation-Type-Value T140 lab
A39	Temporal-Connection-Type-Value E70 during
A40	Observation-Type-Value T146 lab
A41	Temporal-Connection-Type-Value E73 during
A42	Polarity-Value T152 low
A43	Observation-Type-Value T154 measurement
A44	Eq-Temporal-Recency-Value T158 first-time
A45	Eq-Temporal-Period-Value T164 past
A46	Temporal-Connection-Type-Value E83 during
A47	Eq-Temporal-Period-Value T168 past
R1	Caused-By Arg1:E3 Arg2:E5
R2	Abbrev-Of Arg1:E7 Arg2:E10
R4	Caused-By Arg1:E11 Arg2:E38
R3	Caused-By Arg1:T100 Arg2:E38
R5	Example-Of Arg1:E45 Arg2:E44
R6	Caused-By Arg1:E44 Arg2:E38
R7	Example-Of Arg1:E9 Arg2:E44
R8	Example-Of Arg1:E48 Arg2:E44
R9	Abbrev-Of Arg1:E55 Arg2:E54
R10	Example-Of Arg1:E58 Arg2:E53
R11	Treatment-For Arg1:E53 Arg2:E59
R12	Treatment-For Arg1:E64 Arg2:E13
R13	Caused-By Arg1:E74 Arg2:E15
R14	Equivalent-To Arg1:E75 Arg2:E15
R15	Equivalent-To Arg1:E76 Arg2:E15
R16	Caused-By Arg1:E78 Arg2:E17
R17	Equivalent-To Arg1:E17 Arg2:E15
R18	Treatment-For Arg1:E86 Arg2:E85